| Adrenal aging and its implications on stress responsiveness in humans A Yiallouris, C Tsioutis, E Agapidaki, M Zafeiri, AP Agouridis, D Ntourakis, ... Frontiers in endocrinology 10, 54, 2019 | 173 | 2019 |
| An overview of lipid abnormalities in patients with inflammatory bowel disease AP Agouridis, M Elisaf, HJ Milionis Annals of gastroenterology: quarterly publication of the Hellenic Society of …, 2011 | 110 | 2011 |
| The effect of statin therapy on arterial stiffness by measuring pulse wave velocity: a systematic review E C Rizos, A P Agouridis, M S Elisaf Current vascular pharmacology 8 (5), 638-644, 2010 | 97 | 2010 |
| New insights into irritable bowel syndrome: from pathophysiology to treatment A Hadjivasilis, C Tsioutis, A Michalinos, D Ntourakis, DK Christodoulou, ... Annals of gastroenterology 32 (6), 554, 2019 | 76 | 2019 |
| Rosuvastatin treatment is associated with an increase in insulin resistance in hyperlipidaemic patients with impaired fasting glucose MS Kostapanos, HJ Milionis, AD Agouridis, CV Rizos, MS Elisaf International journal of clinical practice 63 (9), 1308-1313, 2009 | 73 | 2009 |
| The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia AP Agouridis, V Tsimihodimos, TD Filippatos, AA Dimitriou, CC Tellis, ... Expert opinion on pharmacotherapy 12 (17), 2605-2611, 2011 | 49 | 2011 |
| Statins and their increased risk of inducing diabetes AP Agouridis, MS Kostapanos, MS Elisaf Expert opinion on drug safety 14 (12), 1835-1844, 2015 | 48 | 2015 |
| Ear lobe crease: a marker of coronary artery disease? AP Agouridis, MS Elisaf, DR Nair, D Mikhailidis Archives of Medical Science 11 (6), 1145-1155, 2015 | 43 | 2015 |
| Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω‐3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic … AP Agouridis, MS Kostapanos, V Tsimihodimos, C Kostara, DP Mikhailidis, ... International journal of clinical practice 66 (9), 843-853, 2012 | 42 | 2012 |
| Does combination therapy with statins and fibrates prevent cardiovascular disease in diabetic patients with atherogenic mixed dyslipidemia? AP Agouridis, CV Rizos, MS Elisaf, TD Filippatos The Review of Diabetic Studies: RDS 10 (2-3), 171, 2013 | 41 | 2013 |
| High doses of rosuvastatin are superior to low doses of rosuvastatin plus fenofibrate or n-3 fatty acids in mixed dyslipidemia AP Agouridis, V Tsimihodimos, TD Filippatos, AD Tselepis, MS Elisaf Lipids 46, 521-528, 2011 | 32 | 2011 |
| Effect of rosuvastatin monotherapy and in combination with fenofibrate or omega-3 fatty acids on serum vitamin D levels SE Makariou, EN Liberopoulos, AP Agouridis, A Challa, M Elisaf Journal of Cardiovascular Pharmacology and Therapeutics 17 (4), 382-386, 2012 | 31 | 2012 |
| The effects of ezetimibe and/or orlistat on triglyceride-rich lipoprotein metabolism in obese hypercholesterolemic patients ES Nakou, TD Filippatos, AP Agouridis, C Kostara, ET Bairaktari, ... Lipids 45, 445-450, 2010 | 28 | 2010 |
| Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in … TD Filippatos, EC Rizos, IF Gazi, K Lagos, D Agouridis, D Mikhailidis, ... Archives of Medical Science 9 (5), 788-795, 2013 | 26 | 2013 |
| Combination of fenofibrate with non-statin drug regimens A P Agouridis, T D Filippatos, C S Derdemezis, D P Mikhailidis, M S Elisaf Current pharmaceutical design 16 (30), 3401-3416, 2010 | 26 | 2010 |
| All for statins and statins for all; an update A P Agouridis, M S Elisaf, D R Nair, D P Mikhailidis Current Pharmaceutical Design 22 (1), 18-27, 2016 | 25 | 2016 |
| Combinations of ezetimibe with nonstatin drug regimens affecting lipid metabolism AP Agouridis, TD Filippatos, V Tsimihodimos, MS Elisaf Expert review of cardiovascular therapy 9 (3), 355-366, 2011 | 23 | 2011 |
| High-density lipoprotein cholesterol: A marker of COVID-19 infection severity? AP Agouridis, A Pagkali, E Zintzaras, EC Rizos, EE Ntzani Atherosclerosis plus 44, 1-9, 2021 | 22 | 2021 |
| Gastric ischemic preconditioning may reduce the incidence and severity of anastomotic leakage after οesophagectomy: a systematic review and meta-analysis A Michalinos, SA Antoniou, D Ntourakis, D Schizas, K Ekmektzoglou, ... Diseases of the Esophagus 33 (10), doaa010, 2020 | 22 | 2020 |
| Strategies to overcome statin intolerance AP Agouridis, DR Nair, DP Mikhailidis Expert Opinion on Drug Metabolism & Toxicology 11 (6), 851-855, 2015 | 21 | 2015 |
Filippatos TheodosiosAssociate Professor of Internal Medicine, Department of Internal Medicine, School of MedicineΗ διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα uoc.gr
